Sustained remission of rheumatoid arthritis with a specific serotonin reuptake inhibitor antidepressant: a case report and review of the literature

INTRODUCTION: The mainstay of pharmacologic therapy for rheumatoid arthritis includes the use of disease-modifying agents like sulfasalazine and methothrexate, and more recently, anti-tumor necrosis factor-α agents. Depression remains a major co-morbidity in patients with rheumatoid arthritis and is...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnadas, Rajeev, Krishnadas, Ranjit, Cavanagh, Jonathan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072330/
https://www.ncbi.nlm.nih.gov/pubmed/21418592
http://dx.doi.org/10.1186/1752-1947-5-112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072330/
https://www.ncbi.nlm.nih.gov/pubmed/21418592
http://dx.doi.org/10.1186/1752-1947-5-112

Ejemplares similares